Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabor Liposits

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Journal of Clinical Medicine|October 14, 2022
The Prognostic Value of Pre-Treatment Circulating Biomarkers of Systemic Inflammation (CRP, dNLR, YKL-40, and IL-6) in Vulnerable Older Patients with Metastatic Colorectal Cancer Receiving Palliative Chemotherapy-The Randomized NORDIC9-StudyGabor Liposits, Halla Skuladottir, Jesper Ryg, et al.
Cancers|June 2, 2021
Quality of Life in Vulnerable Older Patients with Metastatic Colorectal Cancer Receiving Palliative Chemotherapy-The Randomized NORDIC9-StudyGabor Liposits, Henrik Rode Eshøj, Sören Möller, et al.
Journal of Geriatric Oncology|June 30, 2026
Management of older adults with colorectal cancer - The state-of-the-art in 2026Gabor Liposits, Thierry André, Thomas Aparicio, et al.
The Lancet. Gastroenterology & Hepatology|May 19, 2026
Management of colorectal cancer in older adults: an expert panel recommendation to guide daily clinical practiceGabor Liposits, Thierry André, Thomas Aparicio, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 2022
Chemotherapy and gene expression profiling in older early luminal breast cancer patients: An International Society of Geriatric Oncology systematic reviewNicolò Matteo Luca Battisti, Nienke De Glas, Enrique Soto-Perez-de-Celis, et al.
Journal of Geriatric Oncology|May 14, 2020
Caring for older patients with cancer during the COVID-19 pandemic: A Young International Society of Geriatric Oncology (SIOG) global perspectiveIsacco Desideri, Sophie Pilleron, Nicolò Matteo Luca Battisti, et al.
The New England Journal of Medicine|May 3, 2023
Trifluridine-Tipiracil and Bevacizumab in Refractory Metastatic Colorectal CancerGerald W Prager, Julien Taieb, Marwan Fakih, et al.
Acta Oncologica (Stockholm, Sweden)|May 3, 2024
Detailed analysis of metastatic colorectal cancer patients who developed cardiotoxicity on another fluoropyrimidine and switched to S-1 treatment (subgroup analysis of the CardioSwitch-study)Sampsa Kinos, Helga Hagman, Päivi Halonen, et al.
The Lancet. Healthy Longevity|March 24, 2026
Prediction models for overall survival and all-cause mortality risk in older adults with cancer: a systematic reviewPauline Duquenne, Gabor Liposits, Cassandra O Vonnes, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 13, 2025
ESMO-ESTRO consensus statements on the safety of combining radiotherapy with CDK4/6, HER2, PARP, or mTOR inhibitorsEvert S M van Aken, Ajeet Kumar Gandhi, Sean M O'Cathail, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Journal of Clinical Medicine|October 14, 2022
The Prognostic Value of Pre-Treatment Circulating Biomarkers of Systemic Inflammation (CRP, dNLR, YKL-40, and IL-6) in Vulnerable Older Patients with Metastatic Colorectal Cancer Receiving Palliative Chemotherapy-The Randomized NORDIC9-StudyGabor Liposits, Halla Skuladottir, Jesper Ryg, et al.
Cancers|June 2, 2021
Quality of Life in Vulnerable Older Patients with Metastatic Colorectal Cancer Receiving Palliative Chemotherapy-The Randomized NORDIC9-StudyGabor Liposits, Henrik Rode Eshøj, Sören Möller, et al.
Journal of Geriatric Oncology|June 30, 2026
Management of older adults with colorectal cancer - The state-of-the-art in 2026Gabor Liposits, Thierry André, Thomas Aparicio, et al.
The Lancet. Gastroenterology & Hepatology|May 19, 2026
Management of colorectal cancer in older adults: an expert panel recommendation to guide daily clinical practiceGabor Liposits, Thierry André, Thomas Aparicio, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 2022
Chemotherapy and gene expression profiling in older early luminal breast cancer patients: An International Society of Geriatric Oncology systematic reviewNicolò Matteo Luca Battisti, Nienke De Glas, Enrique Soto-Perez-de-Celis, et al.
Journal of Geriatric Oncology|May 14, 2020
Caring for older patients with cancer during the COVID-19 pandemic: A Young International Society of Geriatric Oncology (SIOG) global perspectiveIsacco Desideri, Sophie Pilleron, Nicolò Matteo Luca Battisti, et al.
The New England Journal of Medicine|May 3, 2023
Trifluridine-Tipiracil and Bevacizumab in Refractory Metastatic Colorectal CancerGerald W Prager, Julien Taieb, Marwan Fakih, et al.
Acta Oncologica (Stockholm, Sweden)|May 3, 2024
Detailed analysis of metastatic colorectal cancer patients who developed cardiotoxicity on another fluoropyrimidine and switched to S-1 treatment (subgroup analysis of the CardioSwitch-study)Sampsa Kinos, Helga Hagman, Päivi Halonen, et al.
The Lancet. Healthy Longevity|March 24, 2026
Prediction models for overall survival and all-cause mortality risk in older adults with cancer: a systematic reviewPauline Duquenne, Gabor Liposits, Cassandra O Vonnes, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 13, 2025
ESMO-ESTRO consensus statements on the safety of combining radiotherapy with CDK4/6, HER2, PARP, or mTOR inhibitorsEvert S M van Aken, Ajeet Kumar Gandhi, Sean M O'Cathail, et al.
Pageof 4